Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in Korea

Qlaira® Regulatory Post Marketing Surveillance Study in Korea

The objective of this PMS is to gain information about safety and efficacy in real practice as a regulatory commitment required by KFDA (Korea Food and drug administration)

Inclusion Criteria:

• Signed and dated informed consent
• Women after menarche and before menopause
• Women requesting contraception or Women diagnosed by a physician as having HMB due to non-organic cause who are also requesting contraception
• Women who are prescribed Qlaira® for the first time, during the study period

Exclusion Criteria:

- All contraindications according to the local marketing authorization have to be considered.